BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310
11 results:

  • 1. NIR Fluorescent/Photoacoustic Bimodal Imaging of Ferroptosis in Pancreatic cancer Using Biothiols-Activable Probes.
    Li L; Zhang Z; Zhou L; Ge H; Zhao Y; Gong Y; Mao GJ; Liu H
    Anal Chem; 2024 May; 96(18):7248-7256. PubMed ID: 38655839
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
    Wong KK; Bateman NW; Ng CW; Tsang YTM; Sun CS; Celestino J; Nguyen TV; Malpica A; Hillman RT; Zhang J; Futreal PA; Rojas C; Conrads KA; Hood BL; Dalgard CL; Wilkerson MD; Phippen NT; Conrads TP; Maxwell GL; Sood AK; Gershenson DM
    J Transl Med; 2022 Dec; 20(1):606. PubMed ID: 36528667
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line.
    Jadid MFS; Shademan B; Chavoshi R; Seyyedsani N; Aghaei E; Taheri E; Goleij P; Hajazimian S; Karamad V; Behroozi J; Sabet MN; Isazadeh A; Baradaran B
    Environ Toxicol; 2021 Jun; 36(6):1043-1051. PubMed ID: 33496383
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tumor derived ubr5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
    Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
    Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. E3 ubiquitin ligase ubr5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
    Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
    Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
    Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
    Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Downregulation of the proapoptotic protein MOAP-1 by the ubr5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
    Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
    Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. edd enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
    Bradley A; Zheng H; Ziebarth A; Sakati W; Branham-O'Connor M; Blumer JB; Liu Y; Kistner-Griffin E; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Landen CN; Eblen ST
    Carcinogenesis; 2014 May; 35(5):1100-9. PubMed ID: 24379240
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
    Colombo PE; Boustta M; Poujol S; Jarlier M; Bressolle F; Teulon I; Ladjemi MZ; Pinguet F; Rouanet P; Vert M
    Gynecol Oncol; 2011 Sep; 122(3):632-40. PubMed ID: 21665252
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The E3 ubiquitin ligase edd is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.
    O'Brien PM; Davies MJ; Scurry JP; Smith AN; Barton CA; Henderson MJ; Saunders DN; Gloss BS; Patterson KI; Clancy JL; Heinzelmann-Schwarz VA; Murali R; Scolyer RA; Zeng Y; Williams ED; Scurr L; Defazio A; Quinn DI; Watts CK; Hacker NF; Henshall SM; Sutherland RL
    Br J Cancer; 2008 Mar; 98(6):1085-93. PubMed ID: 18349819
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. edd, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.
    Clancy JL; Henderson MJ; Russell AJ; Anderson DW; Bova RJ; Campbell IG; Choong DY; Macdonald GA; Mann GJ; Nolan T; Brady G; Olopade OI; Woollatt E; Davies MJ; Segara D; Hacker NF; Henshall SM; Sutherland RL; Watts CK
    Oncogene; 2003 Aug; 22(32):5070-81. PubMed ID: 12902990
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.